CCCP decreased TMRE signals in <i>ex vivo</i> perfused hearts. by Akira Kawamoto (444329)

“…(B) Representative images of TMRE signals. Scale bar: 50μm. (C) CCCP decreased the TMRE signals of perfused hearts in a dose-dependent manner 20 min after CCCP perfusion (n = 3–4 per group). …”

Bioluminescence decreased following <i>ex vivo</i> collagenase digestion of transgenic femora. by Sarah E. Mailhiot (766685)

“…Scale bars: (4X) 200 microns (10X) 50 microns.</p>…”

Regions of significantly decreased ACM of SP-MS relative to RR-MS patients. by Mark Lyksborg (583318)

Lymphocytes decreased in mouse pneumonia model. by Qi Xu (134661)

Elevated IDO activity in HD mouse brains is decreased by <i>ex-vivo</i> iron chelation. by David W. Donley (3111198)

“…</b> Striatal IDO activity is increased in N171-82Q HD mice and significantly decreased by <i>ex vivo</i> iron (III) chelation (50 μM deferoxamine). …”

Tax expression is associated with decreased cellular motility. by Saumya Ramanayake (7879091)

Subjects:

Decreased knee bioluminescence was found with increased duration in an <i>in vivo</i> deterioration model. by Sarah E. Mailhiot (766685)

SLE decreases risk for hormonal cancers. by Deborah K. Johnson (10001156)

“…(b) Prostate cancer incidence in male SLE cohort is significantly decreased by SLE status (OR 0.23, 95% CI 0.089, 0.50, p = 0.0053).…”

Comparison of the ISIs that caused 0%, 50% and 100% decreases in response magnitudes (AI spikes, AI fEPSP and MGBv spikes) to succeeding tone. by Colin Xiong (9182695)

An increase in MOI decreases neuronal dendrite numbers. by Emily Z. Tabaie (16630841)

Rg3 decreases HDAC3 expression. by Xiu Shan (62157)

PNs, ORNs and LNs response to a short (50 ms) pulse, similar results of Fig 4. by Mario Pannunzi (553941)

Binding of C4BP decreases the association of CEACAM-binding Opa+ <i>N</i>. <i>gonorrhoeae</i> with neutrophils. by Lacie M. Werner (14710419)

LPS decreases only T cell proliferative response to OKT3. by Fanny Poujol (834338)

DART-ID decreases missing datapoints across runs. by Albert Tian Chen (6900215)

“…Only peptides seen in >50% of experiments are included. (<b>b</b>) Decrease in missing data across all runs after applying DART-ID, for SCoPE-MS and the two bulk sets from <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1007082#pcbi.1007082.g004" target="_blank">Fig 4</a> at 1% FDR. …”

The decrease in hBMVEC death is associated with reduced activation of Caspase-3. by Simona F. Spampinato (773594)

Diclofenac decreases angiogenesis. by Nina Mayorek (241888)

Decreased type I IFN response in B cells carrying the MS-protective class I alleles. by Christian Lundtoft (4068679)

<i>roh</i> mutation results in Rh1 decrease. by Yu Huang (15093)

“…Scale bar, 50 μm. (B) Western blotting showing decreased Rh1 levels in the <i>roh</i>^{<i>EY04039</i>} mutant (<i>ey-flp Rh1</i>::<i>GFP; FRT42D roh</i>^{<i>EY04039</i>}<i>/ FRT42D GMR-hid CL</i>); the INAD and TRP levels are not affected compared to the wild-type. …”

Data_Sheet_1_Switching to second line MS disease-modifying therapies is associated with decreased relapse rate.PDF by James John Marriott (16935942)